Gene Query: STAT5A

Dataset Description Geneva Score
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 146.4
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 86.92
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 86.64
Controlling for gene expression changes in transcription factor protein networks. 77.51
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 72.79
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 61.53
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 55.77
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 49.62
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 45.83
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 45.18
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 45.18
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 45.08
BCL11B 40.35
Transcriptome-wide identification of CELF2 functional targets in T cells 40.31
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 39.64
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 36.88
RNAseq of T-ALL upon long non coding rna purturbation 36.21
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 33.82
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 33.33
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 33.19
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 31.62
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 31.56
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 29.89
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 29.89
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 28.44
RNA-seq data from human lymphoma cell lines 28.3
ChIP-seq and RNA-seq from human lymphoma cell lines 28.3
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 27.97
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 27.74
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 27.74
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 26.76
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 26.26
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 26.13
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 25.42
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 24.85
Spliceosomal disruption of the non-canonical BAF complex in cancer 24.66
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 24.6
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 24.48
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 24.07
Chromatin landscape of human visceral and subcutaneous adipocytes 24.06
Transcriptomes of oxLDL exposed trained monocytes 23.92
oxLDL exposed trained monocytes 23.92
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 23.84
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 23.84
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 23.27
The pause-initiation limit restricts transcription activation in human cells 22.71
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 22.5
Accurate annotation of human protein-coding small open reading frames 21.97
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 21.66
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 21.29
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 20.97
Total RNA-seq in ALL-SIL upon JQ1 inhibition 20.93
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 20.92
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 19.86
Intrahepatic MAIT cell gene expression revealed by RNA-seq 19.71
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 19.58
RNA-sequencing of formalin fixed human primary melanoma tissue 19.34
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 19.1
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 18.95
Global analysis of alternative splicing regulated by RBM10 18.62
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 18.57
Developmental stage specific chromosome architecture in human erythroid cells 18.57
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 17.95
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 16.73
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 16.42
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 16.32
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 16.32
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 16.29
Selective suppression of endothelial cytokine production by progesterone receptor 16.29
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 16.2
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 16.2
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 16.04
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 15.59
Hijacking of stress response machinery by oncogenes in acute leukaemia 15.55
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 15.55
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 15.28
Effect of PRDM11 depletion in U2932 cells 15.12
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 15.09
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 15.09
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 15.0
RNA-seq analysis of differentiating human erythroblasts 14.96
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 14.84
Effect of Influenza virus infection on lncRNA expression in A549 cells 14.81
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 14.76
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 14.63
RNA sequencing of primary human platelets and in vitro cell lines 14.53
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 14.5
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 14.27
The comparison of high-throughput single-cell RNA-seq methods 14.15
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 13.99
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 13.99
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 13.92
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 13.76
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 13.7
snRNAs as regulators of alternative splicing 13.43
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 13.3
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 12.65
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 12.6
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 12.53
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 12.48
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 12.29
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 12.29
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 12.25
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 12.24
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 12.24
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 12.23
The regulartory role of ZCCHC24 in splicing machinery 12.22
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 12.22
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 12.22
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 12.07
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 12.07
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 12.0
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 11.97
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 11.7
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 11.7
Trans-differentiation of human adult peripheral blood T cells into neurons 11.63
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 11.47
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 11.47
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 11.39
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 11.36
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 11.35
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 11.31
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 11.21
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 11.21
Human neutrophil genome during PMA- and E. coli encounter-induced activation 10.99
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 10.99
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 10.91
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 10.67
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.57
Generation and functional characterization of MDSC-like cells 10.55
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 10.54
Transcriptomic analysis of the HOTAIR-regulated genes 10.53
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 10.3
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 10.28
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 10.23
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 10.23
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 10.23
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 10.07
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 10.05
ARS2 is a general suppressor of pervasive transcription [RNAseq] 9.98
RNA-seq analysis of uveal melanoma cells treated with FR900359 9.95
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 9.64
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 9.47
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 9.41
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 9.38
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 9.37
Seletive inhibition of CDK9 in DLBCL cell lines 9.34
Gene expression changes in human melanoma cell lines compared to primary melanocytes 9.17
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 9.11
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 8.92
Landscape and variation of RNA secondary structure across the human transcriptome 8.86
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 8.84
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 8.84
Efficient derivation of microglia-like cells from human pluripotent stem cells 8.83
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 8.8
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 8.76
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 8.73
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 8.71
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 8.71
Clinker: visualizing fusion genes detected in RNA-seq data 8.7
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 8.61
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.61
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.61
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 8.54
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 8.51
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 8.48
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 8.48
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 8.38
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.35
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 8.26
Transcriptome analysis of SKI knock-out in HL60 cells 8.24
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 8.24
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 8.18
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 8.15
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 8.14
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 8.05
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 8.01
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 7.98
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 7.98
CHD1 regulates cell fate determination by activation of differentiation-induced genes 7.92
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 7.89
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 7.89
Solid phase chemistry to covalently and reversibly capture thiolated RNA 7.81
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 7.74
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 7.74
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 7.71
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 7.71
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 7.66
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 7.62
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 7.62
Effect of ILF3 on translation during homeostasis and the antiviral response 7.61
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 7.6
Genes significantly down or Up-regulated upon RNF219 knockdown 7.47
Short and Long RNA sequencing of human mature erythrocytes 7.38
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 7.35
IDH3a KO RNA-seq 7.25
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 7.25
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 7.17
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 7.17
Gene expression changes associated with resistance to tagraxofusp (SL-401) 7.13
Genome wide expression change by RNF168 knocking down in NEC cells 7.09
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.04
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 7.04
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 7.04
Comprehensive comparative analysis of 5’ end RNA sequencing methods 7.03
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 7.02
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 6.96
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.92
RNA seq with AML (NB4) cells upon FTO inhibition 6.83
Genome-wide discovery of human splicing branchpoints [RNAse] 6.81
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 6.78
mRNA-sequencing of breast cancer subtypes and normal tissue 6.74
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 6.72
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 6.72
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 6.71
mRNA expression profile of Lymphocytes by high-throuput sequencing 6.68
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 6.57
NAPRT activation of macrophages 6.57
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 6.5
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 6.48
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.41
MYC dependent mRNA translation shapes gene expression and cell biology 6.38
MEIS1 regulates hematopoiesis in hPSCs 6.33
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 6.29
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 6.29
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 6.22
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 6.22
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 6.17
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 6.12
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 6.12
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 6.12
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 6.1
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 5.98
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 5.98
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 5.98
Transcriptomic analysis of human tonsillar TFH subsets 5.97
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 5.94
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 5.86
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 5.85
Transcriptome of human white and brown adipose tissue biopsies 5.82
Transcriptomic profiling of human peripheral blood-derived mast cells 5.81
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 5.81
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 5.77
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 5.76
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 5.76
RNA-seq of tumor cells following angiopellosis extravasation 5.74
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 5.72
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 5.72
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 5.7
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 5.69
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 5.65
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 5.62
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 5.62
RNA-sequencing of human tendon after injury 5.6
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 5.59
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.58
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 5.56
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.56
RNA-seq of stable and unstable section of human atherosclerotic plaques 5.45
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 5.44
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 5.42
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 5.41
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 5.38
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 5.31
Transcriptome analysis of virus infected tissues 5.3
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 5.24
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 5.18
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 5.17
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 5.1
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 5.1
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 5.1
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 5.1
Global analysis of enhancer targets: Mosaic-seq 5.05
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 5.0
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 5.0
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 4.99
Transcription control by the ENL YEATS domain in acute leukemia 4.99
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 4.98
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 4.85
Reprogrammed myeloid cell transcriptomes in NSCLC 4.82
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 4.8
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 4.79
Transcriptome wide analysis of classically and alternatively activated macrophages 4.77
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 4.76
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 4.76
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 4.76
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 4.74
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 4.69
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 4.65
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 4.65
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 4.59
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 4.59
ZIKV infection of monocytes activates inflammasome pathways 4.59
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 4.52
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 4.52
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 4.52
Regulation of highly expressed hCINAP on translatome 4.48
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 4.45
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 4.43
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 4.43
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 4.41
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 4.41
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 4.41
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 4.39
Tpl-2 small molecule project 4.37
Tpl-2 and MEK small molecule inhibitors 4.37
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 4.25
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 4.25
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 4.24
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 4.23
JAK dependent survival of ALK- ALCL 4.16
MAIT cell RNA sequencing 4.1
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 4.09
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.08
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 4.08
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 4.08
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 4.08
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 4.08
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 4.02
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 4.01
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.01
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 4.0
Genome-wide discovery of human splicing branchpoints 4.0
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 3.97
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.94
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 3.93
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 3.93
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 3.92
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.9
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.9
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 3.87
Functional significance of the HIV-1 Tat signature amino acid residues 3.75
Trascriptome of thyroid cancer-induced macrophages 3.72
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 3.62
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 3.57
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 3.56
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 3.56
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 3.53
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 3.53
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 3.48
Single-Cell Genotyping of Transcriptomes 3.42
RNA-seq of Single-Cell Genotyping of Transcriptomes 3.42
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 3.29
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.19
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.17
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 3.17
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 3.15
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 3.11
The Genetic Landscape of Diamond-Blackfan Anemia 3.07
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 3.07
Cajal bodies are linked to genome conformation [RNA-Seq] 3.04
Cajal bodies are linked to genome conformation 3.04
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 3.01
circRNA profile in hypopharyngeal cancer 2.97
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 2.91
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 2.9
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 2.88
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 2.84
Transcriptome analysis of peripheral blood monocytes 2.84
PRDM1 inhibits proliferation of human colon cancer organoids 2.8
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.79
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 2.79
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 2.77
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.75
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.73
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.71
Transcriptome-wide response to synthetic chromatin protein PcTF 2.71
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 2.71
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.63
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 2.61
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.61
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.44
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.44
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.42
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.34
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.3
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.3
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 2.24
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 2.23
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.23
Stem and effector CD8 T-cells from human cancers 2.23
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.19
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.14
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 2.14
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.13
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.1
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.1
RNA-seq of CD33 KO and control HSPCs 2.06
Human Treg IFNg/IL-10 subpopulations 2.05
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.95
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.92
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.92
Oncogenic roles of ARID5B in T-ALL 1.92
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.91
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.91
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 1.84
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.84
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 1.82
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.82
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.78
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.78
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.77
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.77
Identification of long noncoding RNAs in T-ALL cell lines 1.73
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.73
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 1.67
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.65
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 1.65
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.64
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.64
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.56
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.55
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 1.52
RNAseq analysis of ruxolitinib treated breast cancers 1.52
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.51
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.51
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.49
CD74 role in transcription regulation 1.44
CD74 role in transcription regulation [RNA-seq] 1.44
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.44
Anti-inflammatory effect of indoleacrylic acid (IA) 1.42
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 1.42
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.41
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.38
Impact on erythroid progenitor type on erythroid differntiation 1.32
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.27
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.25
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.24
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.21
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.17
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.07
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.05
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.0
Dermal endothelial cells of type 2 diabetic patients 0.99
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 0.99
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.98
Gene expression profile of CRC-derived HILEC 0.97
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.97
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.97
Targeted enhancer activation by a subunit of the integrator complex 0.96
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.95
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.95
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.92
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.92
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.88
Specific molecular signatures underlie response to decitabine in CMML 0.88
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.88
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.88
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.83
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.83
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.83
Transcriptomic analysis of frontal fibrosing alopecia 0.83
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.8
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.77
The role of m6A/m-RNA methylation in stress response regulation 0.77
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.75
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 0.71
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.7
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.64
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.63
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.62
RNA-seq of primary patient AML samples 0.62
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.59
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.58
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.58
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.58
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 0.58
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.55
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.55
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.54
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.53
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.53
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.47
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 0.47
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.46
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.46
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.44
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.41
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.41
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 0.38
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.36
MARCKS and lnc-MARCKS act as inflammation regulators 0.34
naive T cell heterogeneity after neonatal thymectomy 0.26
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.24
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.24
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.23
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.21
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.2
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.2
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.17
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.17
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.13
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.13
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.12
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.12
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.1
Deep RNA sequencing of the human placental transcriptome 0.1
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.06
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.03
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation